Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,391.40 +56.10 0.37%
S&P 500 1,670.95 +4.66 0.28%
Nasdaq 3,503.62 +7.19 0.21%
Ticker Volume Price Price Delta
STOXX 50 2,821.65 -2.85 -0.10%
FTSE 100 6,803.87 +48.24 0.71%
DAX 8,472.20 +16.37 0.19%
Ticker Volume Price Price Delta
Nikkei 15,381.00 +20.21 0.13%
Hang Seng 23,366.40 -126.66 -0.54%
S&P/ASX 200 5,180.06 -28.98 -0.56%
  • Exchange: -
  • Sector: Consumer, Non-cyclical
  • Industry: Biotechnology
  • Sub-Industry: Medical-Biomedical/Gene

Ablynx NV

ABLXS:BB

Ticker Delisted

Company Profile for Ablynx NV (ABLXS)

Ablynx NV is a biopharmaceutical company. The Company discovers and develops therapeutic protein treatments for human diseases.

Contact Information

Ablynx NV

Technologiepark 21
Zwijnaarde
Ghent, 9052
Belgium
Phone: 32-9-262-00-00
Fax: 32-9-262-00-01

Key Executives for Ablynx NV (ABLXS)

Edwin MosesChairman/CEOWim OttevaereChief Financial Officer
Josefin-Beate Holz "Josi"Chief Medical OfficerAndreas MenradChief Scientific Officer

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil